Hypolipidemic activity of Anethum graveolens in rats

Phytotherapy Research - Tập 22 Số 3 - Trang 372-375 - 2008
Valiollah Hajhashemi1,2, Naser Abbasi3
1Department of Pharmacology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, I. R. Iran
2Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, I. R. Iran
3Department of Pharmacology, School of Medicine, Ilam University of Medical Sciences, Ilam, I. R. Iran

Tóm tắt

AbstractThe aerial parts of Anethum graveolens (dillweed) are used in Iran as a hypolipidemic agent. The scientific basis for its use has yet to be established. In this study the hypolipidemic activity of dill powder and its essential oil (its most important fraction) were evaluated in male Wistar rats (180 ± 20 g) fed a high cholesterol diet. Anethum graveolens essential oil (AGEO) was prepared by hydrodistillation and analysed using GC/MS. AGEO had a yield of 2% and GC/MS analysis showed that α‐phellandrene (32%), limonene (28%) and carvone (28%) were its major components. Daily oral administration of AGEO to rats at doses of 45, 90 and 180 mg/kg for 2 weeks significantly and in a dose‐dependent manner reduced total cholesterol, triglyceride and low density lipoprotein cholesterol (LDL‐C). AGEO also increased significantly high density lipoprotein cholesterol (HDL‐C). Anethum graveolens powder when added to the diet of animals showed similar effects on serum lipids. It is concluded that Anethum graveolens has significant lipid lowering effects and is a promising cardioprotective agent. Copyright © 2007 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

Adams RP, 1995, Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy.

10.1073/pnas.77.7.3957

10.1093/clinchem/20.4.470

Amin GR, 1991, Popular Medicinal Plants of Iran., 101

10.1056/NEJM199508033330502

Basch E, 2003, Therapeutic applications of fenugreek, Altern Med Rev, 8, 20

10.1016/S0378-8741(98)00026-9

10.1073/pnas.80.13.4124

British Pharmacopoeia 1993 HMSO London A137 A138

10.1093/clinchem/19.5.476

10.1021/np50073a022

Ebn‐e Sina A, 1988, Ghanoon dar Teb.

10.1093/tropej/47.3.181

Evans WC, 1996, Trease and Evans' Pharmacognosy, 264

10.1002/j.1875-9114.1988.tb04085.x

Friedwald WT, 1972, Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499

10.1172/JCI107332

Hardman JG, 2001, Goodman & Gilman's The Pharmacological Basis of Therapeutics

10.1016/S0002-9149(02)03144-2

10.1016/S0140-6736(95)92466-3

10.1016/0021-9150(75)90001-5

Leung AY, 1996, Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 210

Lipid Research Clinics Program, 1984, The lipid research clinics coronary primary prevention trial results. i. Reduction in incidence of coronary heart disease, JAMA, 251, 251

10.1001/jama.1984.03340270043026

Mclafferty FW, 1991, The Important Peak Index of the Registry of Mass Spectral Data.

10.1016/S0899-9007(97)83010-9

Rang HP, 1995, Pharmacology, 323

Rifai N, 1992, Measurement of low density lipoprotein cholesterol (LDL‐C) in serum, Clin Chem, 38, 150, 10.1093/clinchem/38.1.150

Sandra P, 1987, Capillary Gas Chromatography in Essential Oil Analysis, 259

Thompson Coon JS, 2003, Herbs for serum cholesterol reduction: a systematic view, J Fam Pract, 52, 468

Yazdanparast R, 2001, Antihyperlipidemic and antihypercholesterolemic effects of Anethum graveolens leaves after removal of furocoumarins, Cytobios, 105, 189

Zargari A, 1991, Medicinal Plants., 528

Thông tin
Thông tin xuất bản

Phytotherapy Research

Tập 22 Số 3

372-375

Thông tin tác giả